Therapeutic Potential of Salvia miltiorrhiza Active Components in Various Diseases Based on the PI3K/Akt Signaling Pathway
Chemistry & Biodiversity · 2026-03 · 23 (3)
DOI: 10.1002/cbdv.202503444 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemistry & Biodiversity, online erschienen am 26.03.2026. Verfasst von Biting Cheng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China. Hauptthemen laut MEDLINE: Salvia miltiorrhiza, Proto-Oncogene Proteins c-akt, Signal Transduction, Phosphatidylinositol 3-Kinases. Die Arbeit nennt 156 Literaturangaben. Gefördert von: Science and Technology Research Project of the Jiangxi Provincial Department of Education, the Science and Technology Project of the Jiangxi Provincial Administration of Traditional Chinese Medicine, the Student Innovation and Entrepreneurship Project of Jiangxi University of Chinese Medicine.
Abstract (Originalsprache)
Salvia miltiorrhiza Bunge, known as danshen in China, is a key medicinal herb in traditional Chinese medicine that has long been used for the treatment of cardiovascular and cerebrovascular disorders. Its principal bioactive constituents fall into two broad categories: water‐soluble phenolic acids (primarily including danshensu, salvianic acid A, salvianolic acid B, and rosmarinic acid) and lipid‐soluble diterpenoids (primarily including tanshinone I, tanshinone IIA, cryptotanshinone, and dihydrotanshinone). Accumulating evidence shows that these active components exert diverse pharmacological effects, including anti‐tumor, anti‐inflammatory, antioxidant, and anti‐neurodegenerative activities, via modulating the phosphatidylinositol 3‐kinase (PI3K)/protein kinase B (Akt) signaling pathway. Consistently, these components hold promising therapeutic potential against various diseases, including cancer, atherosclerosis, Alzheimer's disease, and diabetic nephropathy. Nevertheless, there is still a lack of a comprehensive and systematic summary of the precise mechanisms by which the active ingredients of danshen exert their therapeutic actions against the aforementioned diseases via the PI3K/Akt signaling pathway. To address this gap, this review systematically summarizes the regulatory effects of danshen's active components on the PI3K/Akt signaling pathway, aiming to clarify their therapeutic potential in various pathological conditions and thereby provide novel insights for the basic research and clinical application of danshen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China.
- Nanchang Medical College, Nanchang, Jiangxi, China.
Förderung
- Science and Technology Research Project of the Jiangxi Provincial Department of Education
- the Science and Technology Project of the Jiangxi Provincial Administration of Traditional Chinese Medicine
- the Student Innovation and Entrepreneurship Project of Jiangxi University of Chinese Medicine
- the Doctoral Research Startup Foundation Project of Jiangxi University of Chinese Medicine
Zitieren
APA
Cheng, B., Chen, Y., Cai, F., & Wen, X. (2026). Therapeutic Potential of Salvia miltiorrhiza Active Components in Various Diseases Based on the PI3K/Akt Signaling Pathway. Chemistry & Biodiversity, 23(3). https://doi.org/10.1002/cbdv.202503444
Vancouver
Cheng B, Chen Y, Cai F, Wen X. Therapeutic Potential of Salvia miltiorrhiza Active Components in Various Diseases Based on the PI3K/Akt Signaling Pathway. Chemistry & Biodiversity. 2026;23(3). doi:10.1002/cbdv.202503444
BibTeX
@article{Cheng2026,
author = {Cheng, Biting and Chen, Yan and Cai, Fangyan and Wen, Xiaoli},
title = {Therapeutic Potential of Salvia miltiorrhiza Active Components in Various Diseases Based on the PI3K/Akt Signaling Pathway},
journal = {Chemistry & Biodiversity},
year = {2026},
volume = {23},
number = {3},
doi = {10.1002/cbdv.202503444}
}
EUVIMED